Ontaril

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameOntaril

Drug Alias NameCx-401

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Stem cell therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsCrohn DiseaseRectal Fistula

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlandsAustriaGermany +[5]

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCellerix Sa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCellerix Sa Tigenix Sau

Active IndicationsN/A

Inactive IndicationsCrohn DiseaseRectal Fistula

Other Information

ATC CodeN/A